Conference
Aripazine reverses unfractionated and low molecular weight heparins, fondaparinux and new Xa and IIa oral anticoagulants: report of Phase I/II clinical trial with edoxaban
Authors
Ansell JE; Laulicht B; Bakhru S; Steiner S; Noveck R; Brown K; Grosso M; Morishima Y; Dishy V; Mercuri M
Volume
35
Pagination
pp. 854-855
Publisher
OXFORD UNIV PRESS
Publication Date
September 1, 2014
Name of conference
Annual Meeting of the European-Society-of-Cardiology (ESC)
Conference place
SPAIN, Barcelona
Conference start date
August 30, 2014
Conference end date
September 3, 2014
Conference proceedings
EUROPEAN HEART JOURNAL
ISSN
0195-668X